LeanLife Provides Update on Status of Cease Trade Order and Announces Extension of Warrants
LeanLife Provides Update on Status of Cease Trade Order and Announces Extension of Warrants
Vancouver, British Columbia--(Newsfile Corp. - November 3, 2022) - LeanLife Health Inc. (CSE: LLP) (FSE: LL1) (the "Company" or "LeanLife") announces further to its press release of September 13, 2022, the Company and its auditors are continuing to work diligently to complete the audit of the Company's annual financial statements for the fiscal year ended March 31, 2022, the related management's discussion and analysis and CEO and CFO certifications (collectively, the "Annual Filings") by the prescribed deadline of July 29, 2022. The Company has also failed to file its first Quarter Financial Statements, management's discussion and analysis and CEO and CFO certifications (collectively, the "Interim Filings") for the period ended June 30, 2022.
温哥華，不列顛哥倫比亞省-(Newsfile Corp.-2022年11月3日)-LeanLife Health Inc.. (CSE：LLP) (FSE：LL1)(“公司“或”LeanLife“)繼2022年9月13日的新聞稿後宣佈，公司及其審計師正在繼續勤奮工作，爭取在2022年7月29日的規定截止日期前完成對公司截至2022年3月31日的年度財務報表、相關管理層的討論和分析以及CEO和CFO認證(統稱為”年度申報“)的審計。本公司也未能提交截至2022年6月30日的第一季度財務報表、管理層的討論和分析以及CEO和CFO認證(統稱為”臨時申報“)。
The Company's 2022 audit currently remains ongoing and as previously disclosed, is experiencing delays caused by complexities arising from the Company's financials. The CTO will remain in place until such time as the Annual Filings and Q1 filings are filed by the Company, currently expected before November 4, 2022 respectively.
該公司的2022年審計目前仍在進行中，正如之前披露的那樣，由於公司財務狀況的複雜性而出現了延遲。首席技術官將繼續留任，直到公司提交年度報告和第一季度報告，目前預計分別在2022年11月4日之前提交。
The CTO prohibits the trading by any person of any securities of the Company in each jurisdiction in Canada in which the Company is a reporting issuer, including trades in the Company's common shares made through the Canadian Securities Exchange, for as long as the CTO remains in effect; however, the CTO provides an exception for beneficial securityholders of the Company who are not currently (and who were not as of August 5, 2022 ) insiders or control persons of the Company and who sell securities of the Company acquired before August 5, 2022 if both of the following criteria are met: (i) the sale is made through a "foreign organized regulated market", as defined in section 1.1 of the Universal Market Integrity Rules of the Investment Industry Regulatory Organization of Canada and (ii) the sale is made through an investment dealer registered in a jurisdiction of Canada in accordance with applicable securities legislation.
只要CTO仍然有效，CTO禁止任何人在本公司為報告發行人的加拿大每個司法管轄區內交易本公司的任何證券，包括通過加拿大證券交易所進行的本公司普通股交易；然而，在符合以下兩個條件的情況下，CTO為本公司的實益證券持有人提供了例外，他們目前不是(截至2022年8月5日不是)本公司的內部人士或控制人，並出售在2022年8月5日之前收購的本公司的證券：(I)銷售是通過加拿大投資業監管組織的《全球市場誠信規則》第1.1節所定義的“外國有組織受監管市場”進行的；(Ii)銷售是通過根據適用的證券法在加拿大司法管轄區註冊的投資交易商進行的。
There is no assurance that the Company will be able to remedy its filing default and have the CTO lifted in a timely manner or at all.
不能保證該公司將能夠補救其申請違約並及時或根本取消首席技術官。
The Company is not currently subject to any insolvency proceedings. The Company also confirms that there is no other material information concerning the affairs of the Company that has not been generally disclosed as of the date of this press release.
本公司目前不受任何破產程序的約束。本公司還確認，截至本新聞稿發佈之日，沒有其他有關本公司事務的重大信息尚未全面披露。
The Company further announces that it is has applied to the CSE to extend the expiry date on 20,844,600 warrants expiring on November 30, 2022. The proposed date for the new expiration date is November 20, 2023. The exercise price of the warrants will continue to be $0.075 each.
本公司進一步宣佈，已向聯交所申請延長於2022年11月30日到期的20,844,600份認股權證的到期日。新的到期日建議為2023年11月20日。認股權證的行使價將繼續為每股0.075美元。
About LeanLife Health Inc.
關於LeanLife Health Inc.
LeanLife Health Inc. was born from a desire to offer high-quality omega-3 plant-based oils to the world. Evidence of over 50 years supports the numerous health benefits of flaxseed omega-3 alpha-linolenic acid. LeanLife Health recognized that over 50% of North Americans do not consume enough omega-3 fats and eat far too many omega-6 fats. Our omega-3 flaxseed formulation is stable for 2 years which will allow more food companies to add the oil to their products and more consumers to meet their nutritional needs. Proprietary methods initially developed at a Polish University in 2007 have been continuously improved upon to result in the most nutritionally stable plant-based omega-3 oils that are on the market today.
LeanLife Health Inc.的誕生源於向世界提供高質量的omega-3植物油的願望。超過50年的證據支持亞麻籽omega-3α-亞麻酸對健康的眾多好處。LeanLife Health發現，超過50%的北美人沒有攝入足夠的omega-3脂肪，而攝入了太多的omega-6脂肪。我們的omega-3亞麻籽配方穩定兩年，這將使更多的食品公司將這種油添加到他們的產品中，並讓更多的消費者滿足他們的營養需求。最初於2007年由波蘭一所大學開發的專有方法不斷得到改進，以生產出目前市場上最具營養穩定性的植物基omega-3油。
New initiatives have driven our team to incorporate more products to diversify our offerings and enrich shareholder value. We are excited to be rolling out the Mike Tyson-endorsed Iron Energy Drinks into the soft drink market across the United States in 2021. LeanLife Health Inc. is confident this strategy will propel us forward with positive gains in the foreseeable future.
新的計劃促使我們的團隊採用更多的產品，以使我們的產品多樣化，並增加股東價值。我們很高興能在2021年向全美軟飲料市場推出Mike泰森代言的鐵質能量飲料。LeanLife Health Inc.相信，在可預見的未來，這一戰略將推動我們取得積極的進展。
The Company has engaged a team with global expertise in omega-3 science and production, energy drink sales, and direct-to-consumer marketing. Our professionals are working to ensure our omega-3 flaxseed oil is the healthiest, most stable, and the most convenient available today. In addition, our team is working diligently to launch Amazon and convenience store sales of Iron Energy Drinks (endorsed by Mike Tyson) across the United States.
該公司聘請了一支在omega-3科學和生產、功能飲料銷售和直接面向消費者營銷方面擁有全球專業知識的團隊。我們的專業人員正在努力確保我們的omega-3亞麻籽油是當今最健康、最穩定和最方便的。此外，我們的團隊正在努力在美國各地推出亞馬遜和便利店銷售鐵質能量飲料(由Mike·泰森代言)。
For more information, visit our website at
or contact:
有關更多信息，請訪問我們的網站
或聯繫方式：
Anis Barakat, CEO
(416) 669-4303
anis@leanlifehealth.com
阿尼斯·巴拉卡特，首席執行官
(416) 669-4303
郵箱：anis@leanlife Health.com
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this news release.
加拿大證券交易所及其監管服務提供商(該術語在CSE的政策中定義)均不對本新聞稿的充分性或準確性承擔責任。
Cautionary Note Regarding Forward-Looking Statements
有關前瞻性陳述的注意事項
This release contains certain "forward-looking statements" and certain "forward-looking information" as defined under applicable Canadian securities laws. Forward-looking statements and information can generally be identified by the use of forward-looking terminology such as "may", "will", "expect", "intend", "estimate", "upon" "anticipate", "believe", "continue", "plans" or similar terminology. Forward-looking statements and information include, but are not limited to, statements with respect to the profitability and anticipated sales, product expansion or potential Amazon orders.
本新聞稿包含某些根據適用的加拿大證券法定義的“前瞻性陳述”和某些“前瞻性信息”。前瞻性陳述和信息一般可通過使用“可能”、“將”、“預期”、“打算”、“估計”、“基於”、“預期”、“相信”、“繼續”、“計劃”或類似術語來識別。前瞻性陳述和信息包括但不限於有關盈利能力和預期銷售額、產品擴張或亞馬遜潛在訂單的陳述。
To view the source version of this press release, please visit
要查看本新聞稿的源版本，請訪問
譯文內容由第三人軟體翻譯。